Transitioning to Weekly Administration After the first week, we switch to weekly injections of 1,000 mcg
***If you require needles, please click HERE
EcN can up-regulate the expression and membrane localization of tight junction proteins in intestinal epithelial cells, contribute to repair the damaged mechanical barrier of the intestinal epithelium, and reduce the translocation of intestinal bacteria, lipopolysaccharides, and other hepatotoxic substances to the liver [57]
Safety Considerations and UK Regulatory Status Retatrutide is not MHRA-approved, meaning self-use outside clinical trials carries risks including product impurity, incorrect dosing, gastrointestinal adverse effects, and no pharmacovigilance oversight
We generally suggest wearing one patch per week
The formula (water volume = vial strength target concentration) works for any peptide